Impairment of Glucose Metabolism and Suppression of Stemness in MCF-7/SC Human Breast Cancer Stem Cells by Nootkatone

Targeting cancer stem cell metabolism has emerged as a promising therapeutic strategy for cancer treatment. Breast cancer stem cells (BCSCs) exert distinct metabolism machinery, which plays a major role in radiation and multidrug resistance. Therefore, exploring the mechanisms involved in energy uti...

Full description

Saved in:
Bibliographic Details
Published inPharmaceutics Vol. 14; no. 5; p. 906
Main Authors Nguyen, Yen Thi-Kim, To, Ngoc Bao, Truong, Vi Nguyen-Phuong, Kim, Hee Young, Ediriweera, Meran Keshawa, Lim, Yoongho, Cho, Somi Kim
Format Journal Article
LanguageEnglish
Published Switzerland MDPI AG 21.04.2022
MDPI
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Targeting cancer stem cell metabolism has emerged as a promising therapeutic strategy for cancer treatment. Breast cancer stem cells (BCSCs) exert distinct metabolism machinery, which plays a major role in radiation and multidrug resistance. Therefore, exploring the mechanisms involved in energy utilization of BCSCs could improve the effectiveness of therapeutic strategies aimed at their elimination. This study was conducted to clarify the glucose metabolism machinery and the function of nootkatone, a bioactive component of grapefruit, in regulating glucose metabolism and stemness characteristics in human breast carcinoma MCF-7 stem cells (MCF-7SCs). In vivo experiments, transcriptomic analysis, seahorse XF analysis, MTT assay, Western blotting, mammosphere formation, wound healing, invasion assay, flow cytometric analysis, reverse transcription-quantitative polymerase chain reaction, and in silico docking experiments were performed. MCF-7SCs showed a greater tumorigenic capacity and distinct gene profile with enrichment of the genes involved in stemness and glycolysis signaling pathways compared to parental MCF-7 cells, indicating that MCF-7SCs use glycolysis rather than oxidative phosphorylation (OXPHOS) for their energy supply. Nootkatone impaired glucose metabolism through AMPK activation and reduced the stemness characteristics of MCF-7SCs. In silico docking analysis demonstrated that nootkatone efficiently bound to the active site of AMPK. Therefore, this study indicates that regulation of glucose metabolism through AMPK activation could be an attractive target for BCSCs.
AbstractList Targeting cancer stem cell metabolism has emerged as a promising therapeutic strategy for cancer treatment. Breast cancer stem cells (BCSCs) exert distinct metabolism machinery, which plays a major role in radiation and multidrug resistance. Therefore, exploring the mechanisms involved in energy utilization of BCSCs could improve the effectiveness of therapeutic strategies aimed at their elimination. This study was conducted to clarify the glucose metabolism machinery and the function of nootkatone, a bioactive component of grapefruit, in regulating glucose metabolism and stemness characteristics in human breast carcinoma MCF-7 stem cells (MCF-7SCs). In vivo experiments, transcriptomic analysis, seahorse XF analysis, MTT assay, Western blotting, mammosphere formation, wound healing, invasion assay, flow cytometric analysis, reverse transcription-quantitative polymerase chain reaction, and in silico docking experiments were performed. MCF-7SCs showed a greater tumorigenic capacity and distinct gene profile with enrichment of the genes involved in stemness and glycolysis signaling pathways compared to parental MCF-7 cells, indicating that MCF-7SCs use glycolysis rather than oxidative phosphorylation (OXPHOS) for their energy supply. Nootkatone impaired glucose metabolism through AMPK activation and reduced the stemness characteristics of MCF-7SCs. In silico docking analysis demonstrated that nootkatone efficiently bound to the active site of AMPK. Therefore, this study indicates that regulation of glucose metabolism through AMPK activation could be an attractive target for BCSCs.
Targeting cancer stem cell metabolism has emerged as a promising therapeutic strategy for cancer treatment. Breast cancer stem cells (BCSCs) exert distinct metabolism machinery, which plays a major role in radiation and multidrug resistance. Therefore, exploring the mechanisms involved in energy utilization of BCSCs could improve the effectiveness of therapeutic strategies aimed at their elimination. This study was conducted to clarify the glucose metabolism machinery and the function of nootkatone, a bioactive component of grapefruit, in regulating glucose metabolism and stemness characteristics in human breast carcinoma MCF-7 stem cells (MCF-7SCs). In vivo experiments, transcriptomic analysis, seahorse XF analysis, MTT assay, Western blotting, mammosphere formation, wound healing, invasion assay, flow cytometric analysis, reverse transcription-quantitative polymerase chain reaction, and in silico docking experiments were performed. MCF-7SCs showed a greater tumorigenic capacity and distinct gene profile with enrichment of the genes involved in stemness and glycolysis signaling pathways compared to parental MCF-7 cells, indicating that MCF-7SCs use glycolysis rather than oxidative phosphorylation (OXPHOS) for their energy supply. Nootkatone impaired glucose metabolism through AMPK activation and reduced the stemness characteristics of MCF-7SCs. In silico docking analysis demonstrated that nootkatone efficiently bound to the active site of AMPK. Therefore, this study indicates that regulation of glucose metabolism through AMPK activation could be an attractive target for BCSCs.Targeting cancer stem cell metabolism has emerged as a promising therapeutic strategy for cancer treatment. Breast cancer stem cells (BCSCs) exert distinct metabolism machinery, which plays a major role in radiation and multidrug resistance. Therefore, exploring the mechanisms involved in energy utilization of BCSCs could improve the effectiveness of therapeutic strategies aimed at their elimination. This study was conducted to clarify the glucose metabolism machinery and the function of nootkatone, a bioactive component of grapefruit, in regulating glucose metabolism and stemness characteristics in human breast carcinoma MCF-7 stem cells (MCF-7SCs). In vivo experiments, transcriptomic analysis, seahorse XF analysis, MTT assay, Western blotting, mammosphere formation, wound healing, invasion assay, flow cytometric analysis, reverse transcription-quantitative polymerase chain reaction, and in silico docking experiments were performed. MCF-7SCs showed a greater tumorigenic capacity and distinct gene profile with enrichment of the genes involved in stemness and glycolysis signaling pathways compared to parental MCF-7 cells, indicating that MCF-7SCs use glycolysis rather than oxidative phosphorylation (OXPHOS) for their energy supply. Nootkatone impaired glucose metabolism through AMPK activation and reduced the stemness characteristics of MCF-7SCs. In silico docking analysis demonstrated that nootkatone efficiently bound to the active site of AMPK. Therefore, this study indicates that regulation of glucose metabolism through AMPK activation could be an attractive target for BCSCs.
Author Kim, Hee Young
To, Ngoc Bao
Lim, Yoongho
Cho, Somi Kim
Truong, Vi Nguyen-Phuong
Ediriweera, Meran Keshawa
Nguyen, Yen Thi-Kim
AuthorAffiliation 4 Department of Biological Sciences, Konkuk University, Seoul 05029, Korea; yoongho@konkuk.ac.kr
2 Subtropical—Tropical Organism Gene Bank, Jeju National University, Jeju 63243, Korea; mk.ediriweera@gmail.com
3 Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Colombo, Colombo 00300, Sri Lanka
1 Interdisciplinary Graduate Program in Advanced Convergence Technology and Science, Jeju National University, Jeju 63243, Korea; ntkyen.hcmus@gmail.com (Y.T.-K.N.); tobaongoc.hcmus@gmail.com (N.B.T.); phuongvi.truongnguyen@gmail.com (V.N.-P.T.); hi.khyoung@gmail.com (H.Y.K.)
AuthorAffiliation_xml – name: 1 Interdisciplinary Graduate Program in Advanced Convergence Technology and Science, Jeju National University, Jeju 63243, Korea; ntkyen.hcmus@gmail.com (Y.T.-K.N.); tobaongoc.hcmus@gmail.com (N.B.T.); phuongvi.truongnguyen@gmail.com (V.N.-P.T.); hi.khyoung@gmail.com (H.Y.K.)
– name: 4 Department of Biological Sciences, Konkuk University, Seoul 05029, Korea; yoongho@konkuk.ac.kr
– name: 3 Department of Biochemistry and Molecular Biology, Faculty of Medicine, University of Colombo, Colombo 00300, Sri Lanka
– name: 2 Subtropical—Tropical Organism Gene Bank, Jeju National University, Jeju 63243, Korea; mk.ediriweera@gmail.com
Author_xml – sequence: 1
  givenname: Yen Thi-Kim
  orcidid: 0000-0001-7111-031X
  surname: Nguyen
  fullname: Nguyen, Yen Thi-Kim
– sequence: 2
  givenname: Ngoc Bao
  surname: To
  fullname: To, Ngoc Bao
– sequence: 3
  givenname: Vi Nguyen-Phuong
  orcidid: 0000-0002-6099-767X
  surname: Truong
  fullname: Truong, Vi Nguyen-Phuong
– sequence: 4
  givenname: Hee Young
  surname: Kim
  fullname: Kim, Hee Young
– sequence: 5
  givenname: Meran Keshawa
  orcidid: 0000-0001-9393-9516
  surname: Ediriweera
  fullname: Ediriweera, Meran Keshawa
– sequence: 6
  givenname: Yoongho
  surname: Lim
  fullname: Lim, Yoongho
– sequence: 7
  givenname: Somi Kim
  orcidid: 0000-0002-0980-2005
  surname: Cho
  fullname: Cho, Somi Kim
BackLink https://www.ncbi.nlm.nih.gov/pubmed/35631492$$D View this record in MEDLINE/PubMed
BookMark eNp9kstu1TAQhiNURC_0EUCW2LAJtWMnjoWEBFEvR2phcWBt2c6k9SGxg-0g9e3x6WlRWyG88WW--T3-x4fFnvMOiuINwR8oFfhkvlFhUgaWZE0kDNdY4OZFcUCEECUTFd17tN4vjmPc4DwoJS0Vr4p9WjeU5NhBsaymWdkwgUvID-h8XIyPgK4gKe1HGyekXI_WyzwHiNF6t6XWCSaXt8g6dNWdlfxk3aGLZVIOfQmgYkKdcgbCHYg6GMeI9C366n36qVJ-yuvi5aDGCMf381Hx4-z0e3dRXn47X3WfL0tT4zqVoNlgKs0M7XnfClxh3VRca0p7aKBnMABT3DCNqQaNgRgmRNsOYqgHbnBPj4rVTrf3aiPnYCcVbqVXVt4d-HAtVcgejiCrdjCi1bhXamCkZZqTFjhTVPSUE8Gy1qed1rzoCXqTHQtqfCL6NOLsjbz2v6UgrMZVmwXe3wsE_2uBmORko8nmKAd-ibJqOKk4r2qR0XfP0I1fgstWbancx0xVmXr7uKK_pTx0NwMfd4AJPsYAgzQ2qZS7mAu0oyRYbr-T_Od3ytn1s-yHC_6f9weEXNSG
CitedBy_id crossref_primary_10_1021_acs_jafc_2c07543
crossref_primary_10_3390_ijms231911340
crossref_primary_10_3390_pharmaceutics14091884
crossref_primary_10_1016_j_heliyon_2024_e36226
crossref_primary_10_3389_fphar_2024_1423115
crossref_primary_10_3390_metabo13030345
crossref_primary_10_1007_s12672_024_00978_2
crossref_primary_10_1016_j_abb_2024_110192
crossref_primary_10_3390_cells14010010
crossref_primary_10_1016_j_ijbiomac_2024_139367
Cites_doi 10.1155/2018/5416923
10.1016/j.tibs.2015.12.001
10.1016/j.bioorg.2020.104294
10.1016/j.stemcr.2019.08.015
10.1038/emm.2016.16
10.1016/j.chembiol.2014.05.014
10.1093/gbe/evt129
10.1111/j.1432-1033.1995.tb20498.x
10.18632/oncotarget.3629
10.1007/s00253-009-1968-x
10.1126/science.1112014
10.1016/j.cmet.2017.10.009
10.1016/j.phymed.2019.153000
10.1038/s41598-017-14364-2
10.1042/BJ20141142
10.1016/j.trecan.2017.08.007
10.5483/BMBRep.2018.51.7.112
10.1016/j.cell.2006.01.016
10.1158/1535-7163.MCT-15-0621
10.4161/cbt.9.12.12347
10.1016/j.ajpath.2011.03.005
10.1038/cddis.2014.285
10.1186/s12943-016-0555-x
10.1007/978-1-4939-8876-1_10
10.1126/science.1215327
10.1038/nrm.2017.95
10.3390/nu10121829
10.1016/S2214-109X(20)30215-1
10.1371/journal.pone.0053372
10.1016/j.biocel.2012.08.022
10.1073/pnas.0530291100
10.1002/jcp.22264
10.1186/s13058-016-0712-6
10.1016/j.ccr.2013.01.022
10.1007/s00441-007-0466-7
10.1016/j.febslet.2008.06.044
10.1093/protein/8.2.127
10.1038/onc.2009.252
10.1186/s12885-020-07379-y
10.1371/journal.pone.0122889
10.1200/JCO.2007.15.1829
10.3390/ijms18122574
10.1002/9781118670613
10.1006/meth.2001.1262
10.3390/nu12061663
10.1369/jhc.2010.955773
10.1016/S0092-8674(03)00929-2
10.3892/or.2021.7924
10.3389/fgene.2019.01119
10.1126/science.1160809
10.1016/j.bmc.2017.07.062
10.1152/ajpendo.00774.2009
ContentType Journal Article
Copyright 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
2022 by the authors. 2022
Copyright_xml – notice: 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
– notice: 2022 by the authors. 2022
DBID AAYXX
CITATION
NPM
3V.
7XB
8FK
8G5
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
GNUQQ
GUQSH
M2O
MBDVC
PHGZM
PHGZT
PIMPY
PKEHL
PQEST
PQQKQ
PQUKI
PRINS
Q9U
7X8
5PM
DOA
DOI 10.3390/pharmaceutics14050906
DatabaseName CrossRef
PubMed
ProQuest Central (Corporate)
ProQuest Central (purchase pre-March 2016)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Research Library
ProQuest Central (Alumni)
ProQuest Central UK/Ireland
ProQuest Central Essentials - QC
ProQuest Central (New)
ProQuest One Community College
ProQuest Central Korea
ProQuest Central Student
ProQuest Research Library
ProQuest Research Library
Research Library (Corporate)
ProQuest Central Premium
ProQuest One Academic (New)
Publicly Available Content Database
ProQuest One Academic Middle East (New)
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
ProQuest Central Basic
MEDLINE - Academic
PubMed Central (Full Participant titles)
DOAJ (Directory of Open Access Journals)
DatabaseTitle CrossRef
PubMed
Publicly Available Content Database
Research Library Prep
ProQuest Central Student
ProQuest One Academic Middle East (New)
ProQuest Central Basic
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Central (Alumni Edition)
ProQuest One Community College
Research Library (Alumni Edition)
ProQuest Central China
ProQuest Central
ProQuest One Academic UKI Edition
ProQuest Central Korea
ProQuest Research Library
ProQuest Central (New)
ProQuest One Academic
ProQuest One Academic (New)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList Publicly Available Content Database

CrossRef

PubMed
MEDLINE - Academic
Database_xml – sequence: 1
  dbid: DOA
  name: DOAJ (Directory of Open Access Journals)
  url: https://www.doaj.org/
  sourceTypes: Open Website
– sequence: 2
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central (New)
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Pharmacy, Therapeutics, & Pharmacology
EISSN 1999-4923
ExternalDocumentID oai_doaj_org_article_28fc98b0daaf4184b718e74a39d37194
PMC9145028
35631492
10_3390_pharmaceutics14050906
Genre Journal Article
GeographicLocations United States--US
GeographicLocations_xml – name: United States--US
GrantInformation_xml – fundername: National Research Foundation of Korea
  grantid: 2020R1A2C1004349
– fundername: Ministry of Education
  grantid: 2016R1A6A1A03012862
GroupedDBID ---
53G
5VS
8G5
AADQD
AAYXX
ABDBF
ABUWG
ACGFO
ACIHN
ACUHS
AEAQA
AFKRA
AFZYC
ALMA_UNASSIGNED_HOLDINGS
AZQEC
BENPR
BPHCQ
CCPQU
CITATION
DIK
DWQXO
EBD
ESX
F5P
FD6
GNUQQ
GROUPED_DOAJ
GUQSH
GX1
HH5
HYE
IAO
IHR
ITC
KQ8
M2O
M48
MK0
MODMG
M~E
OK1
P6G
PGMZT
PHGZM
PHGZT
PIMPY
PQQKQ
PROAC
RNS
RPM
TR2
TUS
3V.
NPM
7XB
8FK
MBDVC
PKEHL
PQEST
PQUKI
PRINS
Q9U
7X8
5PM
PUEGO
ID FETCH-LOGICAL-c505t-eb4fc2b4c3d7d89020b627bb33de6ed4efe4a7c4b03beb0e1c49988f9f5f7c0d3
IEDL.DBID M48
ISSN 1999-4923
IngestDate Wed Aug 27 01:31:45 EDT 2025
Thu Aug 21 13:59:26 EDT 2025
Fri Jul 11 05:03:19 EDT 2025
Mon Jun 30 07:29:10 EDT 2025
Thu Jan 02 22:54:28 EST 2025
Tue Jul 01 03:36:12 EDT 2025
Thu Apr 24 23:04:24 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords cancer metabolism
AMPK
breast cancer stem cells
nootkatone
oxidative phosphorylation
glycolysis
Language English
License https://creativecommons.org/licenses/by/4.0
Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c505t-eb4fc2b4c3d7d89020b627bb33de6ed4efe4a7c4b03beb0e1c49988f9f5f7c0d3
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
These authors contributed equally to this work.
ORCID 0000-0002-0980-2005
0000-0002-6099-767X
0000-0001-7111-031X
0000-0001-9393-9516
OpenAccessLink http://journals.scholarsportal.info/openUrl.xqy?doi=10.3390/pharmaceutics14050906
PMID 35631492
PQID 2670337252
PQPubID 2032349
ParticipantIDs doaj_primary_oai_doaj_org_article_28fc98b0daaf4184b718e74a39d37194
pubmedcentral_primary_oai_pubmedcentral_nih_gov_9145028
proquest_miscellaneous_2671277259
proquest_journals_2670337252
pubmed_primary_35631492
crossref_citationtrail_10_3390_pharmaceutics14050906
crossref_primary_10_3390_pharmaceutics14050906
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 20220421
PublicationDateYYYYMMDD 2022-04-21
PublicationDate_xml – month: 4
  year: 2022
  text: 20220421
  day: 21
PublicationDecade 2020
PublicationPlace Switzerland
PublicationPlace_xml – name: Switzerland
– name: Basel
PublicationTitle Pharmaceutics
PublicationTitleAlternate Pharmaceutics
PublicationYear 2022
Publisher MDPI AG
MDPI
Publisher_xml – name: MDPI AG
– name: MDPI
References Eyler (ref_34) 2008; 26
Inoki (ref_15) 2003; 115
Lin (ref_38) 2010; 9
Dong (ref_8) 2013; 23
Wullschleger (ref_13) 2006; 124
Guo (ref_54) 2020; 104
Liberti (ref_6) 2016; 41
Livak (ref_23) 2001; 25
Tan (ref_31) 2016; 15
Murase (ref_18) 2010; 299
Cantley (ref_5) 2009; 324
ref_21
Wicha (ref_51) 2003; 100
ref_20
Marchitti (ref_42) 2010; 58
Kim (ref_43) 2016; 48
Storci (ref_39) 2010; 225
Mori (ref_41) 2019; 13
ref_26
Corton (ref_44) 1995; 229
Heer (ref_1) 2020; 8
Hawley (ref_45) 2012; 336
Moon (ref_22) 2021; 45
Pestell (ref_7) 2016; 18
Chae (ref_10) 2018; 51
Keng (ref_4) 2011; 9
Soeda (ref_9) 2009; 28
ref_33
Kim (ref_24) 2017; 25
ref_30
Yu (ref_35) 2012; 44
Zhang (ref_32) 2013; 5
Eketunde (ref_53) 2020; 12
Moreno (ref_46) 2008; 582
Lin (ref_16) 2018; 27
Jensen (ref_48) 2015; 467
Deshmukh (ref_11) 2016; 15
Hung (ref_19) 2019; 63
Herzig (ref_14) 2018; 19
Li (ref_50) 2017; 7
Carninci (ref_37) 2005; 309
Li (ref_12) 2015; 6
Phi (ref_27) 2018; 2018
ref_3
Ciavardelli (ref_28) 2014; 5
ref_2
Popov (ref_52) 2011; 179
Ramos (ref_49) 2017; 3
Li (ref_36) 2019; 10
Wallace (ref_25) 1995; 8
Aigner (ref_40) 2008; 331
Vangapandu (ref_29) 2019; 1881
Hunter (ref_47) 2014; 21
Fraatz (ref_17) 2009; 83
References_xml – volume: 2018
  start-page: 5416923
  year: 2018
  ident: ref_27
  article-title: Cancer Stem Cells (CSCs) in Drug Resistance and their Therapeutic Implications in Cancer Treatment
  publication-title: Stem Cells Int.
  doi: 10.1155/2018/5416923
– volume: 41
  start-page: 211
  year: 2016
  ident: ref_6
  article-title: The Warburg Effect: How Does it Benefit Cancer Cells?
  publication-title: Trends Biochem. Sci.
  doi: 10.1016/j.tibs.2015.12.001
– volume: 104
  start-page: 104294
  year: 2020
  ident: ref_54
  article-title: Discovery, biological evaluation and docking studies of novel N-acyl-2-aminothiazoles fused (+)-nootkatone from Citrus paradisi Macf. as potential α-glucosidase inhibitors
  publication-title: Bioorg. Chem.
  doi: 10.1016/j.bioorg.2020.104294
– volume: 13
  start-page: 730
  year: 2019
  ident: ref_41
  article-title: ALDH-Dependent Glycolytic Activation Mediates Stemness and Paclitaxel Resistance in Patient-Derived Spheroid Models of Uterine Endometrial Cancer
  publication-title: Stem Cell Rep.
  doi: 10.1016/j.stemcr.2019.08.015
– volume: 48
  start-page: e224
  year: 2016
  ident: ref_43
  article-title: AMPK activators: Mechanisms of action and physiological activities
  publication-title: Exp. Mol. Med.
  doi: 10.1038/emm.2016.16
– volume: 21
  start-page: 866
  year: 2014
  ident: ref_47
  article-title: Mechanism of action of compound-13: An α1-selective small molecule activator of AMPK
  publication-title: Chem. Biol.
  doi: 10.1016/j.chembiol.2014.05.014
– volume: 5
  start-page: 1781
  year: 2013
  ident: ref_32
  article-title: Mitochondrial-nuclear interactions: Compensatory evolution or variable functional constraint among vertebrate oxidative phosphorylation genes?
  publication-title: Genome Biol. Evol.
  doi: 10.1093/gbe/evt129
– volume: 229
  start-page: 558
  year: 1995
  ident: ref_44
  article-title: 5-aminoimidazole-4-carboxamide ribonucleoside. A specific method for activating AMP-activated protein kinase in intact cells?
  publication-title: Eur. J. Biochem.
  doi: 10.1111/j.1432-1033.1995.tb20498.x
– volume: 6
  start-page: 7365
  year: 2015
  ident: ref_12
  article-title: Targeting AMPK for cancer prevention and treatment
  publication-title: Oncotarget
  doi: 10.18632/oncotarget.3629
– volume: 83
  start-page: 35
  year: 2009
  ident: ref_17
  article-title: Nootkatone—A biotechnological challenge
  publication-title: Appl. Microbiol. Biotechnol.
  doi: 10.1007/s00253-009-1968-x
– volume: 309
  start-page: 1559
  year: 2005
  ident: ref_37
  article-title: The transcriptional landscape of the mammalian genome
  publication-title: Science
  doi: 10.1126/science.1112014
– volume: 27
  start-page: 299
  year: 2018
  ident: ref_16
  article-title: AMPK: Sensing Glucose as well as Cellular Energy Status
  publication-title: Cell Metab.
  doi: 10.1016/j.cmet.2017.10.009
– volume: 63
  start-page: 153000
  year: 2019
  ident: ref_19
  article-title: Nootkatone, an AMPK activator derived from grapefruit, inhibits KRAS downstream pathway and sensitizes non-small-cell lung cancer A549 cells to adriamycin
  publication-title: Phytomedicine
  doi: 10.1016/j.phymed.2019.153000
– volume: 7
  start-page: 13856
  year: 2017
  ident: ref_50
  article-title: Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
  publication-title: Sci. Rep.
  doi: 10.1038/s41598-017-14364-2
– volume: 467
  start-page: 461
  year: 2015
  ident: ref_48
  article-title: PT-1 selectively activates AMPK-γ1 complexes in mouse skeletal muscle, but activates all three γ subunit complexes in cultured human cells by inhibiting the respiratory chain
  publication-title: Biochem. J.
  doi: 10.1042/BJ20141142
– volume: 3
  start-page: 780
  year: 2017
  ident: ref_49
  article-title: New Opportunities and Challenges to Defeat Cancer Stem Cells
  publication-title: Trends Cancer
  doi: 10.1016/j.trecan.2017.08.007
– volume: 51
  start-page: 319
  year: 2018
  ident: ref_10
  article-title: Cancer stem cell metabolism: Target for cancer therapy
  publication-title: BMB Rep.
  doi: 10.5483/BMBRep.2018.51.7.112
– volume: 124
  start-page: 471
  year: 2006
  ident: ref_13
  article-title: TOR signaling in growth and metabolism
  publication-title: Cell
  doi: 10.1016/j.cell.2006.01.016
– volume: 15
  start-page: 774
  year: 2016
  ident: ref_31
  article-title: The Role of PGC1α in Cancer Metabolism and its Therapeutic Implications
  publication-title: Mol. Cancer Ther.
  doi: 10.1158/1535-7163.MCT-15-0621
– volume: 9
  start-page: 949
  year: 2010
  ident: ref_38
  article-title: Impact of the hypoxic tumor microenvironment on the regulation of cancer stem cell characteristics
  publication-title: Cancer Biol. Ther.
  doi: 10.4161/cbt.9.12.12347
– volume: 179
  start-page: 2
  year: 2011
  ident: ref_52
  article-title: The role of breast cancer stem cells in metastasis and therapeutic implications
  publication-title: Am. J. Pathol.
  doi: 10.1016/j.ajpath.2011.03.005
– volume: 5
  start-page: e1336
  year: 2014
  ident: ref_28
  article-title: Breast cancer stem cells rely on fermentative glycolysis and are sensitive to 2-deoxyglucose treatment
  publication-title: Cell Death Dis.
  doi: 10.1038/cddis.2014.285
– volume: 15
  start-page: 69
  year: 2016
  ident: ref_11
  article-title: Cancer stem cell metabolism: A potential target for cancer therapy
  publication-title: Mol. Cancer
  doi: 10.1186/s12943-016-0555-x
– volume: 1881
  start-page: 121
  year: 2019
  ident: ref_29
  article-title: Extracellular Flux Assays to Determine Oxidative Phosphorylation and Glycolysis in Chronic Lymphocytic Leukemia Cells
  publication-title: Methods Mol. Biol.
  doi: 10.1007/978-1-4939-8876-1_10
– volume: 336
  start-page: 918
  year: 2012
  ident: ref_45
  article-title: The ancient drug salicylate directly activates AMP-activated protein kinase
  publication-title: Science
  doi: 10.1126/science.1215327
– volume: 19
  start-page: 121
  year: 2018
  ident: ref_14
  article-title: AMPK: Guardian of metabolism and mitochondrial homeostasis
  publication-title: Nat. Rev. Mol. Cell Biol.
  doi: 10.1038/nrm.2017.95
– ident: ref_21
  doi: 10.3390/nu10121829
– volume: 8
  start-page: e1027
  year: 2020
  ident: ref_1
  article-title: Global burden and trends in premenopausal and postmenopausal breast cancer: A population-based study
  publication-title: Lancet Glob. Health
  doi: 10.1016/S2214-109X(20)30215-1
– ident: ref_26
  doi: 10.1371/journal.pone.0053372
– volume: 44
  start-page: 2144
  year: 2012
  ident: ref_35
  article-title: Cancer stem cells
  publication-title: Int. J. Biochem. Cell Biol.
  doi: 10.1016/j.biocel.2012.08.022
– volume: 100
  start-page: 3983
  year: 2003
  ident: ref_51
  article-title: Prospective identification of tumorigenic breast cancer cells
  publication-title: Proc. Natl. Acad. Sci. USA
  doi: 10.1073/pnas.0530291100
– volume: 225
  start-page: 682
  year: 2010
  ident: ref_39
  article-title: TNFalpha up-regulates SLUG via the NF-kappaB/HIF1alpha axis, which imparts breast cancer cells with a stem cell-like phenotype
  publication-title: J. Cell. Physiol.
  doi: 10.1002/jcp.22264
– volume: 18
  start-page: 55
  year: 2016
  ident: ref_7
  article-title: Cancer stem cell metabolism
  publication-title: Breast Cancer Res.
  doi: 10.1186/s13058-016-0712-6
– volume: 23
  start-page: 316
  year: 2013
  ident: ref_8
  article-title: Loss of FBP1 by Snail-mediated repression provides metabolic advantages in basal-like breast cancer
  publication-title: Cancer Cell
  doi: 10.1016/j.ccr.2013.01.022
– volume: 331
  start-page: 225
  year: 2008
  ident: ref_40
  article-title: TGF-beta in neural stem cells and in tumors of the central nervous system
  publication-title: Cell Tissue Res.
  doi: 10.1007/s00441-007-0466-7
– volume: 12
  start-page: e8010
  year: 2020
  ident: ref_53
  article-title: Diabetes as a Risk Factor for Breast Cancer
  publication-title: Cureus
– volume: 582
  start-page: 2650
  year: 2008
  ident: ref_46
  article-title: A769662, a novel activator of AMP-activated protein kinase, inhibits non-proteolytic components of the 26S proteasome by an AMPK-independent mechanism
  publication-title: FEBS Lett.
  doi: 10.1016/j.febslet.2008.06.044
– volume: 8
  start-page: 127
  year: 1995
  ident: ref_25
  article-title: LIGPLOT: A program to generate schematic diagrams of protein-ligand interactions
  publication-title: Protein Eng.
  doi: 10.1093/protein/8.2.127
– volume: 28
  start-page: 3949
  year: 2009
  ident: ref_9
  article-title: Hypoxia promotes expansion of the CD133-positive glioma stem cells through activation of HIF-1alpha
  publication-title: Oncogene
  doi: 10.1038/onc.2009.252
– ident: ref_20
  doi: 10.1186/s12885-020-07379-y
– ident: ref_30
  doi: 10.1371/journal.pone.0122889
– volume: 26
  start-page: 2839
  year: 2008
  ident: ref_34
  article-title: Survival of the fittest: Cancer stem cells in therapeutic resistance and angiogenesis
  publication-title: J. Clin. Oncol.
  doi: 10.1200/JCO.2007.15.1829
– ident: ref_2
  doi: 10.3390/ijms18122574
– ident: ref_33
  doi: 10.1002/9781118670613
– volume: 25
  start-page: 402
  year: 2001
  ident: ref_23
  article-title: Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method
  publication-title: Methods
  doi: 10.1006/meth.2001.1262
– ident: ref_3
  doi: 10.3390/nu12061663
– volume: 58
  start-page: 765
  year: 2010
  ident: ref_42
  article-title: Aldehyde dehydrogenase 3B1 (ALDH3B1): Immunohistochemical tissue distribution and cellular-specific localization in normal and cancerous human tissues
  publication-title: J. Histochem. Cytochem.
  doi: 10.1369/jhc.2010.955773
– volume: 115
  start-page: 577
  year: 2003
  ident: ref_15
  article-title: TSC2 mediates cellular energy response to control cell growth and survival
  publication-title: Cell
  doi: 10.1016/S0092-8674(03)00929-2
– volume: 45
  start-page: 1133
  year: 2021
  ident: ref_22
  article-title: Catechol enhances chemo- and radio-sensitivity by targeting AMPK/Hippo signaling in pancreatic cancer cells
  publication-title: Oncol. Rep.
  doi: 10.3892/or.2021.7924
– volume: 10
  start-page: 1119
  year: 2019
  ident: ref_36
  article-title: Tumor Characterization in Breast Cancer Identifies Immune-Relevant Gene Signatures Associated with Prognosis
  publication-title: Front. Genet.
  doi: 10.3389/fgene.2019.01119
– volume: 324
  start-page: 1029
  year: 2009
  ident: ref_5
  article-title: Understanding the Warburg effect: The metabolic requirements of cell proliferation
  publication-title: Science
  doi: 10.1126/science.1160809
– volume: 25
  start-page: 5423
  year: 2017
  ident: ref_24
  article-title: Biological evaluation of 2-pyrazolinyl-1-carbothioamide derivatives against HCT116 human colorectal cancer cell lines and elucidation on QSAR and molecular binding modes
  publication-title: Bioorg. Med. Chem.
  doi: 10.1016/j.bmc.2017.07.062
– volume: 299
  start-page: E266
  year: 2010
  ident: ref_18
  article-title: Nootkatone, a characteristic constituent of grapefruit, stimulates energy metabolism and prevents diet-induced obesity by activating AMPK
  publication-title: Am. J. Physiol. Endocrinol. Metab.
  doi: 10.1152/ajpendo.00774.2009
– volume: 9
  start-page: 13
  year: 2011
  ident: ref_4
  article-title: Isolation and comparison of tumorigenicity of different cell populations from the MCF-7 breast cancer cell line based on CD44 and CD24 markers
  publication-title: Vietnam J. Biotechnol.
SSID ssj0000331839
Score 2.3144002
Snippet Targeting cancer stem cell metabolism has emerged as a promising therapeutic strategy for cancer treatment. Breast cancer stem cells (BCSCs) exert distinct...
SourceID doaj
pubmedcentral
proquest
pubmed
crossref
SourceType Open Website
Open Access Repository
Aggregation Database
Index Database
Enrichment Source
StartPage 906
SubjectTerms AMPK
Breast cancer
breast cancer stem cells
cancer metabolism
Cancer therapies
Cell culture
Chemotherapy
Energy
Glucose
glycolysis
Kinases
Metabolism
nootkatone
oxidative phosphorylation
Population
Radiation therapy
Software
Stem cells
Tumors
SummonAdditionalLinks – databaseName: DOAJ (Directory of Open Access Journals)
  dbid: DOA
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Ja9wwFBYlp15K906bBhVKTnFHlmTLPiam07QwIZAEcjNaycDEE8aew_z7vmc5s5RALr3akq3lbZ_0FkK-a62CTZlLgi4AoDhgKRMCSzCqsxRep6a_0Z1e5Oc38s9tdrtT6gt9wmJ64LhwY14EWxaGOa2DBDhiQJh6JbUonVCAwFH6gs7bAVO9DBZIq2UM2RGA68cPd9sj4hZQBShKrHK0o4z6nP1PGZr_-kvuKKDJa_JqsBzpaRzxG_LCN2_J8WX84fqEXm8jqdoTekwvt0mp1-_I6jfw_WyJZ4F0Eeiv6KlOp74DKpjP2nuqG0exxmd0jG2w1VXn71EU0llDp9UkUeOrivbH_vQMndk7WiHRLPuGtPLzeUvNml4sFh3GJTX-PbmZ_LyuzpOh5EJiwRTqEm9ksNxIK5xyeAXJTM6VMUI4n3snffBSKysNE8Yb5lMLiKkoQhmyoCxz4gM5aODznwgNDEwvl-ZKaxAUMhSF5waMmUJpDjqRj4h8XPvaDvnIsSzGvAZcgltWP7llI_Jj0-0hJuR4rsMZbuymMebT7h8AldUDldXPUdmIHD6SRT0weVvzHMSlUDyDuXzbvAb2xDsX3fjFqm-TckAwWTkiHyMVbUYislwAQIXeao--9oa6_6aZ3fUpwMtUZmAZfv4fc_tCXnKM6WAy4ekhOeiWK_8VLK3OHPVM9Rc_ISr8
  priority: 102
  providerName: Directory of Open Access Journals
– databaseName: ProQuest Central (New)
  dbid: BENPR
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwhV3Nb9MwFLdgu3BBjM_AQEZCOy00sZ04OSFarQykVhXbpN0iO7a3Sl1SmvTQ_37vJWm6ogmusZ1Y8fv6Pb8PQr4oJV0eBsZ3KgGAYoCltHOBj1mdKbcq1M2N7mQan1-JX9fRdedwq7qwyq1MbAS1KXP0kQ9YDLTJJYvYt-UfH7tG4e1q10LjKTkEEZwA-Docnk1nv3svCyxBE6BN3eGA7wfL252ruAJ0AQoTux09UEpN7f7HDM6_4yYfKKLxC_K8syDp9_bIj8gTW7wkJ7P2g5tTernLqKpO6Qmd7YpTb16R9U_g__kKfYK0dPRHG7FOJ7YGaljMqzuqCkOx12cbIFvgrIva3qFIpPOCTkZjXw4uRrRx_9MhBrXXdITEs2om0pFdLCqqN3RaljXmJxX2Nbkan12Ozv2u9YKfg0lU-1YLlzMtcm6kwavIQMdMas25sbE1wjorlMyFDri2OrBhDsgpSVzqIifzwPA35KCA178j1AVggpkwlkqBwBAuSSzTYNQkUjHQjcwjYvvvs7yrS47tMRYZ4BM8suzRI_PI137Zsi3M8b8FQzzYfjLW1W4elKubrGPTjCUuTxMdGKWcAPCrQXVbKRRPDZdhKjxyvCWLrGP2KtuRpkc-98PApnj3ogpbrps5IQMkE6UeedtSUb8THsUcgCqslnv0tbfV_ZFiftuUAk9DEYGF-P7f2_pAnjHM2giEz8JjclCv1vYj2FK1_tQxzD2dBiQH
  priority: 102
  providerName: ProQuest
Title Impairment of Glucose Metabolism and Suppression of Stemness in MCF-7/SC Human Breast Cancer Stem Cells by Nootkatone
URI https://www.ncbi.nlm.nih.gov/pubmed/35631492
https://www.proquest.com/docview/2670337252
https://www.proquest.com/docview/2671277259
https://pubmed.ncbi.nlm.nih.gov/PMC9145028
https://doaj.org/article/28fc98b0daaf4184b718e74a39d37194
Volume 14
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwlV3db9MwELem7YUXxDeFURkJ7WnZEtuJkweEaLUykFpVbJX2FtmxvVXK0tGmEv3vuXPSlqIixGv8kcS-r5_Pd0fIB6WkK6LQBE6lAFAMsJR2LgwwqjPjVkXae3SHo-RyIr7dxDcHZJ1QoV3AxV5oh_WkJvPy7OeP1Sdg-I-IOAGynz_cbU9_FwAYQAdiEu4jUE4SeXXYWvxeOHMk4sz7mjOsr8Z4E9fz95l2NJZP7L_PGv3zUuVvWmrwhDxuzUv6uaGHp-TAVs_Iybh54eqUXm_DrRan9ISOt5mrV8_J8isIh-kcDwzpzNEvzXV2OrQ1kEo5XdxTVRmKhUCb27MV9rqq7T3KSzqt6LA_COT5VZ963wDt4Y33mvaRsua-I-3bslxQvaKj2azG4KXKviCTwcV1_zJo6zIEBdhLdWC1cAXTouBGGvRThjphUmvOjU2sEdZZoWQhdMi11aGNCoBVaeoyFztZhIa_JIcVTP-aUBeCfWaiRCoF0kS4NLVMg8WTSsVAcbIOEeu1z4s2aTnWzihzAC-4ZfneLeuQs82whyZrx78G9HBjN50x6bZ_MJvf5i0P5yx1RZbq0CjlBCBjDXrdSqF4ZriMMtEhx2uyyNeEnLMEZCqXLIZ_eb9pBh5Gx4yq7Gzp-0QMYE6cdcirhoo2X8LjhAOKhdFyh752PnW3pZre-TzhWSRiMB_f_O9ivCWPGAZ5hCJg0TE5rOdL-w5Mr1p3yVHvYjT-3vVHF13PWr8Alpkz_g
linkProvider Scholars Portal
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV3Nb9MwFLdGd4ALGt9lA4wEOy00sZ04OSBEy0rL1qpinbRbZsc2q9QlpUmF-k_xN_KcpO2KJjjtGtuJlff83vv5fSH0TghuEs9VjhEhABQFR0oa4zo2qzOiWniy9OgOhkHvnH278C920O9VLowNq1zJxFJQqyyxd-QtEgBvUk588mn207Fdo6x3ddVCo2KLE738BZAt_9j_AvR9T0j3eNzpOXVXAScBbV84WjKTEMkSqriyXjZXBoRLSanSgVZMG80ET5h0qdTS1V4CoCAMTWR8wxNXUXjvPbTLKECZBtptHw9H39e3OrBFa3JUqUKURm5rdrW5ms4BzYCCtt2VbijBslfAbQbu33GaNxRfdw89rC1W_LlisUdoR6eP0eGo-uDyCI83GVz5ET7Eo00x7OUTtOiDvJnM7R0kzgz-WkXI44EugPumk_wai1Rh21u0CshN7ayzQl9bEYwnKR50ug5vnXVw6W7AbRtEX-COZdZ5ORF39HSaY7nEwywrbD5Uqp-i8zshyjPUSOH1LxA2Lph8ygu4ECCgmAlDTSQYUSEXBHQxaSK2-vdxUtdBt-04pjHgIUuy-FaSNdGH9bJZVQjkfwvalrDrybaOd_kgm_-Ia7EQk9AkUShdJYRhALYlmAqaM0EjRbkXsSY6WLFFXAuXPN4chSZ6ux4GsWB9PSLV2aKc4xFATn7URM8rLlrvhPoBBWAMq_kWf21tdXsknVyVpccjj_lgkb7897beoPu98eA0Pu0PT_bRA2IzRlzmEO8ANYr5Qr8CO66Qr-vDg9HlXZ_XP2nWY04
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1bb9MwFLZGJyFeEHcKA4wEe1qoYztx8oAQ7VZWxqqKbdLeMju2WaUuKU0q1L_Gr-M4SdsVTfC018ZOrZzr53ND6J2UwqY-0Z6VEQAUDSKlrCWeq-qMmZG-qiK6x8Pw8Ix_PQ_Ot9DvZS2MS6tc6sRKUes8dXfkHRoCbzJBA9qxTVrEaL__afrTcxOkXKR1OU6jZpEjs_gF8K34ONgHWr-ntH9w2jv0mgkDXgqWv_SM4jaliqdMC-0ibkSFVCjFmDah0dxYw6VIuSJMGUWMnwJAiCIb28CKlGgG772DtgWgItJC292D4ej76oYHjuvcj7psiLGYdKaX62vqApANGGs3aemaQazmBtzk7P6ds3nNCPYfoPuN94o_1-z2EG2Z7BHaHdV_uNjDp-tqrmIP7-LRujH24jGaD0D3jGfuPhLnFn-ps-XxsSmBEyfj4grLTGM3Z7ROzs3cqpPSXDl1jMcZPu71PdE56eEq9IC7LqG-xD3HuLNqIe6ZyaTAaoGHeV662qjMPEFnt0KUp6iVweufI2wJuH_aD4WUoKy4jSJDFThUkZAU7DJtI7789kna9ER3ozkmCWAjR7LkRpK10YfVtmndFOR_G7qOsKvFrqd39UM--5E0KiKhkU3jSBEtpeUAvBW4DUZwyWLNhB_zNtpZskXSKJoiWYtFG71dPQYV4eI-MjP5vFrjU0BRQdxGz2ouWp2EBSEDkAy7xQZ_bRx180k2vqzakMc-D8A7ffHvY71Bd0FOk2-D4dFLdI-64hHCPervoFY5m5tX4NKV6nUjOxhd3La4_gGRYGeD
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Impairment+of+Glucose+Metabolism+and+Suppression+of+Stemness+in+MCF-7%2FSC+Human+Breast+Cancer+Stem+Cells+by+Nootkatone&rft.jtitle=Pharmaceutics&rft.au=Nguyen%2C+Yen+Thi-Kim&rft.au=To%2C+Ngoc+Bao&rft.au=Truong%2C+Vi+Nguyen-Phuong&rft.au=Kim%2C+Hee+Young&rft.date=2022-04-21&rft.issn=1999-4923&rft.eissn=1999-4923&rft.volume=14&rft.issue=5&rft.spage=906&rft_id=info:doi/10.3390%2Fpharmaceutics14050906&rft.externalDBID=n%2Fa&rft.externalDocID=10_3390_pharmaceutics14050906
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1999-4923&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1999-4923&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1999-4923&client=summon